VE1 (BRAF V600E) immunohistochemistry in colorectal cancer: Validation, assessment of heterogeneity and clinicopathological associations in three colorectal cancer cohorts

被引：0
|
作者：
Schafroth, C. [1 ]
Galvan, J. A. [1 ]
Sokol, L. [1 ]
Rieger, G. [1 ]
Dawson, H. E. [1 ]
Koelzer, V. H. [1 ]
Langer, R. [1 ]
Lugli, A. [1 ]
Zlobec, I. [1 ]
机构：
[1] Univ Bern, Inst Pathol, CH-3012 Bern, Switzerland
来源：
VIRCHOWS ARCHIV | 2015年 / 467卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-16-001
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [31] BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression
    Barras, David
    Missiaglia, Edoardo
    Wirapati, Pratyaksha
    Sieber, Oliver M.
    Jorissen, Robert N.
    Love, Chris
    Molloy, Peter L.
    Jones, Ian T.
    McLaughlin, Stephen
    Gibbs, Peter
    Guinney, Justin
    Simon, Iris M.
    Roth, Arnaud D.
    Bosman, Fred T.
    Tejpar, Sabine
    Delorenzi, Mauro
    CLINICAL CANCER RESEARCH, 2017, 23 (01) : 104 - 115
  • [32] BRAF V600E confers resistance to cetuximab or panitumumab metastatic colorectal cancer
    Di Nicolantonio, F.
    Martini, M.
    Molinari, F.
    Bianchi, A. Sartore
    Arena, S.
    Saletti, P.
    Mazzucchelli, L.
    Frattini, M.
    Siena, S.
    Bardelli, A.
    EJC SUPPLEMENTS, 2008, 6 (12): : 81 - 81
  • [33] Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
    Guerrero, Rodrigo Motta
    Labajos, Veronica Arnao
    Ballena, Sophia Lozano
    Macha, Carlos Aliaga
    Lezama, Miguel Sotelo
    Roman, Cristian Pacheco
    Beltran, Paola Montenegro
    Torrejon, Alejandro Figueroa
    ECANCERMEDICALSCIENCE, 2022, 16
  • [34] Clinical characteristics in colorectal cancer harboring BRAF V600E and non-V600E mutations
    Shinozaki, E.
    Miki, Y.
    Ueno, M.
    Igarashi, M.
    Chin, K.
    Takahari, D.
    Ogura, M.
    Ichimura, T.
    Nakayama, I.
    Osumi, H.
    Wakatsuki, T.
    Matsushima, T.
    Yamaguchi, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [35] Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review
    Dvorak, Katerina
    Higgins, Amanda
    Palting, John
    Cohen, Michael
    Brunhoeber, Patrick
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (01) : 349 - 359
  • [36] BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer
    Ros, Javier
    Baraibar, Iosune
    Sardo, Emilia
    Mulet, Nuria
    Salva, Francesc
    Argiles, Guillem
    Martini, Giulia
    Ciardiello, Davide
    Cuadra, Jose Luis
    Tabernero, Josep
    Elez, Elena
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [37] Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens
    Loes, Inger Marie
    Immervoll, Heike
    Angelsen, Jon-Helge
    Horn, Arild
    Geisler, Juergen
    Busch, Christian
    Lonning, Per Eystein
    Knappskog, Stian
    TUMOR BIOLOGY, 2015, 36 (02) : 1003 - 1013
  • [38] V600E and Non-V600E BRAF Mutations in Colorectal Cancer: Clinicopathologic Correlations in a Single Institution
    Simsek, Cem
    Lacin, Sahin
    Ece, Esin
    Yalcin, Suayib
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2021, 31 (01): : 43 - 49
  • [39] Molecular characteristic profile in early colorectal cancer with V600E and non-V600E BRAF mutations
    An, Zhang Quan
    CANCER RESEARCH, 2024, 84 (06)
  • [40] Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1
    Liu, Hui
    Li, Zhongwu
    Wang, Yan
    Feng, Qin
    Si, Lu
    Cui, Chuanliang
    Guo, Jun
    Xue, Weicheng
    PATHOLOGY INTERNATIONAL, 2014, 64 (12) : 601 - 606
12345